The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Open accessAbstract
Objective: To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Methods: This international initiative had four phases. 1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta‐regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort, and a patient survey. 2) Criteria reduction by Delphi and nominal group technique exercises. 3) Criteria definition and weighting based on criterion performance and on results of a multi‐criteria decision analysis. 4) Refinement of weights and threshold scores in a new derivation cohort of 1,001 subjects and validation compared with previous criteria in a new validation cohort of 1,270 subjects. Results: The 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in 7 clinical (constitutional, hematologic, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and 3 immunologic (antiphospholipid antibodies, complement proteins, SLE‐specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria. Conclusion: These new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered, and weighted criteria reflects current thinking about SLE and provides an improved foundation for SLE research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The EULAR/ACR criteria do not recommend a method.”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Positivity for polyreactive aCL antibodies is a criterion in the classification of two autoimmune conditions: APS and SLE251,252.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [251]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibodies to dsDNA are an important laboratory parameter for diagnosis, monitoring and classification of systemic lupus erythematosus (SLE).”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The latest EULAR/ACR SLE classification criteria (2019) stated that the test to measure anti-dsDNA autoantibodies should have a specificity of at least 90% [28].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Neither do they specify which immunoglobulin isotype should be tested.”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“the assessment of whether studies measured specificity in a relevant disease control group was guided by the derivation and validation cohorts used to develop the 2019 EULAR/ACR classification criteria”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [2]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“the EULAR/ACR noted that some anti-dsDNA tests used in practice have relatively low specificity (2).”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Self-citationTsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,814
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,663
Rahman, M. U. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,018
Manson, J. J., & Rahman, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-6 · Cited by 607
Wallace, D. J., Stohl, W., Furie, R. A., LISSE, J. R., McKay, J. D., Merrill, J. T., Petri, M., Ginzler, E. M., Chatham, W. W., McCune, W. J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24699 · Cited by 585
Self-citation
Cited by
Sorted by citations
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Boeltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simón, D., Kleyer, A., Munoz, L. E., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,166
Anders, H., Saxena, R., Zhao, M., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 1,032
Kiriakidou, M., & Ching, C. L. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202006020 · Cited by 854
Update οn the diagnosis and management of systemic lupus erythematosus
Fanouriakis, A., Tziolos, N., Bertsias, G. K., & Boumpas, D. T. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218272 · Cited by 776
Self-citationGlobal epidemiology of systemic lupus erythematosus
Barber, M. R. W., Drenkard, C., Falasinnu, T., Hoi, A. Y.-B., Mak, A., Kow, N. Y., Svenungsson, E., Peterson, J., Clarke, A. E., & Ramsey‐Goldman, R. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00668-1 · Cited by 763
Self-citationTian, J., Zhang, D., Yao, X., Huang, Y., & Lu, Q. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223035 · Cited by 631
Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus
Perez, R. K., Gordon, M. G., Subramaniam, M., Kim, M. C., Hartoularos, G. C., Targ, S., Sun, Y., Ogorodnikov, A., Bueno, R., Lu, A. C., et al. (2022) · Science · doi:10.1126/science.abf1970 · Cited by 535
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M.-C., Amoura, Z., Andrade, D., Andreoli, L., Artim-Esen, B., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224609 · Cited by 493
Self-citationThe 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria
Barbhaiya, M., Zuily, S., Naden, R., Hendry, A. M., Manneville, F., Amigo, M., Amoura, Z., ANDRADE, D. C. O. D., Andréoli, L., Artım-Esen, B., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42624 · Cited by 519
Self-citation2025 ESC Guidelines for the management of myocarditis and pericarditis
Schulz‐Menger, J., Collini, V., Gröschel, J., Adler, Y., Brucato, A. L., Christian, V., Ferreira, V. M., Gandjbakhch, E., Heidecker, B., Kernéis, M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf192 · Cited by 563
Devreese, K. M. J., de Groot, P. G., de Laat, B., Erkan, D., Favaloro, E. J., Mackie, I., Martinuzzo, M., Ortel, T. L., Pengo, V., Rand, J. H., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15047 · Cited by 467
Hoi, A. Y.-B., Igel, T. F., Mok, C. C., & Arnaud, L. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00398-2 · Cited by 440
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Crow, M. K. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223741 · Cited by 435
Self-citationEpstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 381
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management
Ameer, M. A., Chaudhry, H., Mushtaq, J., Khan, O. S., Babar, M., Hashim, T., Zeb, S., Tariq, M. A., Patlolla, S. R., Ali, J., et al. (2022) · Cureus · doi:10.7759/cureus.30330 · Cited by 379
Kiriakidou, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-01004 · Cited by 333
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 315
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis
Gracia‐Ramos, A. E., Martín‐Nares, E., & Hernández‐Molina, G. (2021) · Cells · doi:10.3390/cells10123592 · Cited by 306
Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice
Ni, H., Wang, Y., Yao, K., Wang, L., Huang, J., Xiao, Y., Chen, H., Liu, B., Yang, C. Y., & Zhao, J. (2024) · Nature Communications · doi:10.1038/s41467-023-43650-z · Cited by 306
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Furie, R. A., Rovin, B. H., Garg, J. P., Santiago, M. B., Aroca, G., Santillán, A. E. Z., Álvarez, D., Sandoval, C. N., Lila, A. M., Tumlin, J. A., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2410965 · Cited by 270
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 328
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches
Lazar, S., & Kahlenberg, J. M. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032611 · Cited by 244
Inflammatory markers in systemic lupus erythematosus
Aringer, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102374 · Cited by 229
Self-citationClinical and Immunological Biomarkers for Systemic Lupus Erythematosus
Yu, H., Nagafuchi, Y., & Fujio, K. (2021) · Biomolecules · doi:10.3390/biom11070928 · Cited by 228
A Review of Complement Activation in SLE
Weinstein, A., Alexander, R. V., & Zack, D. J. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00984-1 · Cited by 205
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity
Alissafi, T., Kalafati, L., Lazari, M., Filia, A., Kloukina, I., Manifava, M., Lim, J.-H., Alexaki, V. I., Ktistakis, N. T., Doskas, T. K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.001 · Cited by 198
Self-citationUnderstanding and interpreting antinuclear antibody tests in systemic rheumatic diseases
Bossuyt, X., Langhe, E. D., Borghi, M. O., & Meroni, P. L. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00522-w · Cited by 193
Self-citationEULAR/ACR classification criteria for SLE
Aringer, M. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.09.009 · Cited by 184
Self-citationAutoimmune diseases and atherosclerotic cardiovascular disease
Porsch, F., & Binder, C. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01045-7 · Cited by 155
IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
Murdaca, G., Greco, M., Tonacci, A., Negrini, S. M., Borro, M., Puppo, F., & Gangemi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235856 · Cited by 149
Izmirly, P., Kim, M., Samanovic, M. I., Fernandez‐Ruiz, R., Ohana, S., Deonaraine, K., Engel, A., Masson, M., Xie, X., Cornelius, A. R., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41937 · Cited by 147
Self-citationHuang, C., Yi, P., Zhu, M., Zhou, W., Zhang, B., Yi, X., Long, H., Zhang, G., Wu, H., Tsokos, G. C., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102844 · Cited by 139
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Thanou, A., Jupe, E. R., Purushothaman, M., Niewold, T. B., & Munroe, M. E. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102615 · Cited by 140
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
Hartl, J., Serpas, L., Wang, Y., Rashidfarrokhi, A., Perez, O. A., Sally, B., Sisirak, V., Soni, C., Khodadadi‐Jamayran, A., Tsirigos, A., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201138 · Cited by 130
Self-citationWoo, J. M. P., Parks, C. G., Jacobsen, S., Costenbader, K. H., & Bernatsky, S. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13448 · Cited by 129
Self-citationPrecision medicine in systemic lupus erythematosus
Fasano, S., Milone, A., Nicoletti, G. F., Isenberg, D. A., & Ciccia, F. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00948-y · Cited by 133
Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention
Zhang, L., Qing, P., Yang, H., Wu, Y., Liu, Y., & Luo, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686501 · Cited by 132
Frazzei, G., van Vollenhoven, R., de Jong, B. A., Siegelaar, S. E., & van Schaardenburg, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.899372 · Cited by 137
Islam, M. A., Khandker, S. S., Kotyla, P. J., & Hassan, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01477 · Cited by 131
Diagnosis of mast cell activation syndrome: a global "consensus-2"
Afrin, L. B., Ackerley, M. B., Bluestein, L. S., Brewer, J. H., Brook, J. B., Buchanan, A. D., Cuni, J. R., Davey, W. P., Dempsey, T. T., Dorff, S. R., et al. (2021) · Diagnosis · doi:10.1515/dx-2020-0005 · Cited by 115
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Zaslavsky, M., Craig, E., Michuda, J., Sehgal, N., Ram-Mohan, N., Lee, J.-Y., Nguyen, K. D., Hoh, R. A., Pham, T. D., Röltgen, K., et al. (2025) · Science · doi:10.1126/science.adp2407 · Cited by 132
Adamichou, C., Genitsaridi, I., Nikolopoulos, D., Nikoloudaki, M., Repa, A., Bortoluzzi, A., Fanouriakis, A., Sidiropoulos, P. I., Boumpas, D. T., & Bertsias, G. K. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219069 · Cited by 123
Self-citationDevelopment of Classification Criteria for the Uveitides
Jabs, D. A., McCluskey, P., Oden, N., Palestine, A. G., Peterson, J. S., Saleem, S. M., Thorne, J. E., & Trusko, B. E. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.03.061 · Cited by 120
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
Stull, C., Sprow, G., & Werth, V. P. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.220089 · Cited by 134
Systemic lupus erythematosus and cardiovascular disease
Frostegård, J. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13557 · Cited by 116
Amarnani, R., Yeoh, S., Denneny, E. K., & Wincup, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.610257 · Cited by 108
Complement as a Biomarker for Systemic Lupus Erythematosus
Ayano, M., & Horiuchi, T. (2023) · Biomolecules · doi:10.3390/biom13020367 · Cited by 100
Adamichou, C., Nikolopoulos, D., Genitsaridi, I., Bortoluzzi, A., Fanouriakis, A., Papastefanakis, E., Kalogiannaki, E., Gergianaki, I., Sidiropoulos, P. I., Boumpas, D. T., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216155 · Cited by 102
Self-citationSociety for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy
Silver, R. M., Craigo, S., Porter, F., Osmundson, S. S., Kuller, J. A., & Norton, M. E. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.09.001 · Cited by 106
Classifying and diagnosing systemic lupus erythematosus in the 21st century
Aringer, M., & Johnson, S. R. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa379 · Cited by 106
Self-citationSystemic Lupus Erythematosus Management in Pregnancy
Dao, K. H., & Bermas, B. L. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s282604 · Cited by 118
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Law, C., Wacleche, V. S., Cao, Y., Pillai, A., Sowerby, J. M., Hancock, B. L., Horisberger, A., Bracero, S., Skidanova, V., Li, Z., et al. (2024) · Nature · doi:10.1038/s41586-024-07627-2 · Cited by 104
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review
Gracia‐Ramos, A. E., & Saavedra, M. Á. (2021) · Rheumatology International · doi:10.1007/s00296-021-04794-7 · Cited by 92
Barbhaiya, M., Zuily, S., Ahmadzadeh, Y., Amigo, M., Avčin, T., Bertolaccini, M. L., Branch, D. W., de Jesús, G. R., Devreese, K. M. J., Francès, C., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24520 · Cited by 95
Self-citationAli, O. H., Bomze, D., Risch, L., Brugger, S. D., Paprotny, M., Weber, M. C., Thiel, S. L., Kern, L., Albrich, W. C., Kohler, P. P., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1496 · Cited by 89
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis
Vojinovic, T., Cavazzana, I., Ceruti, P., Fredi, M., Modina, D., Berlendis, M., & Franceschini, F. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08814-5 · Cited by 89
Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis
Walter, I. J., Haneveld, M. J. K., Lely, A. T., Bloemenkamp, K. W. M., Limper, M., & Kooiman, J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102901 · Cited by 93
Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
Yan, B., Chen, X., Ye, L., Chen, J., Zheng, M., & Man, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649408 · Cited by 90
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Dunlap, G. S., Billi, A. C., Xing, X., Ma, F., Maz, M. P., Tsoi, L. C., Wasikowski, R., Hodgin, J. B., Gudjonsson, J. E., Kahlenberg, J. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156341 · Cited by 86
Opportunities and limitations of B cell depletion approaches in SLE
Stockfelt, M., Teng, Y. K. O., & Vital, E. M. J. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01210-9 · Cited by 86
Self-citationThe 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease
Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., Fuller, A., Rosenthal, A. K., Becce, F., Bardin, T., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42619 · Cited by 92
Self-citationvon Mühlen, C. A., Torre, I. G.-D. L., Infantino, M. G., Damoiseaux, J. G. M. C., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantônio, P. L. C., Fritzler, M. J., Herold, M., et al. (2021) · Immunologic Research · doi:10.1007/s12026-021-09233-0 · Cited by 86
Self-citationSystemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review
Shin, J. I., Lee, K. H., Park, S., Yang, J. W., Kim, H. J., Song, K., Lee, S., Na, H., Jang, Y. J., Nam, J. Y., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226714 · Cited by 81
Hocaoǧlu, M., Valenzuela-Almada, M. O., Dabit, J. Y., Osei‐Onomah, S., Chevet, B., Giblon, R. E., Zand, L., Fervenza, F. C., Helmick, C. G., Crowson, C. S., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42375 · Cited by 80
Khunsriraksakul, C., Li, Q., Markus, H., Patrick, M. T., Sauteraud, R., McGuire, D., Wang, X., Wang, C., Wang, L., Chen, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36306-5 · Cited by 79
Mok, C. C., Hamijoyo, L., Kasitanon, N., Chen, D. Y., Chen, S., Yamaoka, K., Oku, K., Li, M. T., Zamora, L. D., Bae, S., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00009-6 · Cited by 77
Self-citationdo Vale, E. C. S., & Garcia, L. C. (2023) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2022.09.005 · Cited by 95
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., Fuller, A., Rosenthal, A. K., Becce, F., Bardin, T., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224575 · Cited by 81
Self-citationGlomerular Hematuria and the Utility of Urine Microscopy: A Review
Saha, M. K., Massicotte‐Azarniouch, D., Reynolds, M. L., Mottl, A. K., Falk, R. J., Jennette, J. C., & Derebail, V. K. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.02.022 · Cited by 78
Disrupted degradative sorting of TLR7 is associated with human lupus
Mishra, H., Schlack-Leigers, C., Lim, E. L., Thieck, O., Magg, T., Raedler, J., Wolf, C., Klein, C., Ewers, H., Lee‐Kirsch, M. A., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi9575 · Cited by 74
Systemic Lupus Erythematosus Management in Pregnancy
Dao, K. H., & Bermas, B. L. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 73
Duarte‐García, A., Hocaoǧlu, M., Valenzuela-Almada, M. O., Osei‐Onomah, S., Dabit, J. Y., Sánchez-Rodríguez, A., Duong, S. Q., Giblon, R. E., Langenfeld, H. E., Alarcón, G. S., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222276 · Cited by 73
The global epidemiology of SLE: narrowing the knowledge gaps
Barber, M. R. W., Falasinnu, T., Ramsey‐Goldman, R., & Clarke, A. E. (2022) · Rheumatology · doi:10.1093/rheumatology/keac610 · Cited by 77
Self-citationAringer, M., Brinks, R., Dörner, T., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219373 · Cited by 68
Self-citationLaboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances
Vandevelde, A., & Devreese, K. M. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082164 · Cited by 76
Evolving story of autoantibodies in systemic lupus erythematosus
Pisetsky, D. S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102356 · Cited by 70
Aringer, M., Leuchten, N., & Johnson, S. R. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00896-6 · Cited by 73
Self-citationVandevelde, A., Chayoua, W., de Laat, B., Gris, J., Moore, G. W., Musiał, J., Zuily, S., Wahl, D., & Devreese, K. M. J. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15585 · Cited by 66
Fernandez‐Ruiz, R., Masson, M., Kim, M., Myers, B., Haberman, R. H., Castillo, R., Scher, J. U., Guttmann, A., Carlucci, P. M., Deonaraine, K., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41450 · Cited by 62
Self-citationNew classification criteria for systemic lupus erythematosus
Aringer, M., & Petri, M. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000740 · Cited by 67
Self-citationClinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)
Neven, Q., Boulanger, C., Bruwier, A., de Goyet, M. D. V., Meyts, I., Moens, L., Damme, A. V., & Brichard, B. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00883-7 · Cited by 62
Díaz-Gallo, L.-M., Oke, V., Lundström, E., Elvin, K., Wu, Y. L., Eketjäll, S., Zickert, A., Gustafsson, J. T., Jönsen, A., Leonard, D., et al. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11343 · Cited by 60
Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis
Essouma, M., Nkeck, J. R., Endomba, F. T., Bigna, J. J., Singwé–Ngandeu, M., & HACHULLA, E. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102348 · Cited by 63
Aringer, M., Costenbader, K. H., Dörner, T., & Johnson, S. R. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218615 · Cited by 60
Self-citationOne year in review 2021: systemic lupus erythematosus
Trentin, F., Zucchi, D., Signorini, V., Elefante, E., Bortoluzzi, A., & Tani, C. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/7gzsxp · Cited by 60
Self-citationAndrade, L. E. C., Damoiseaux, J. G. M. C., Vergani, D., & Fritzler, M. J. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100145 · Cited by 64
Self-citationJohnson, S. R., Brinks, R., Costenbader, K. H., Daikh, D., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217162 · Cited by 59
Self-citationLongitudinal Immune Cell Profiling in Patients With Early Systemic Lupus Erythematosus
Sasaki, T., Bracero, S., Keegan, J., Chen, L., Cao, Y., Stevens, E. F., Qu, Y., Wang, G., Nguyen, J. P., Sparks, J. A., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42248 · Cited by 55
Self-citationRecent advances in understanding the genetic basis of systemic lupus erythematosus
Ha, E., Bae, S., & Kim, K.-W. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00900-w · Cited by 57
Choi, M. Y., & Costenbader, K. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890522 · Cited by 58
Self-citationClinical patterns of disease: From early systemic lupus erythematosus to late-onset disease
Piga, M., Tselios, K., Viveiros, L., Chessa, E., Neves, A., Urowitz, M. B., & Isenberg, D. A. (2023) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101938 · Cited by 59
Self-citationZavala-Flores, E., Salcedo-Matienzo, J., Quiroz-Alva, A., & Berrocal-Kasay, A. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05980-5 · Cited by 54
The standardisation of uveitis nomenclature ( SUN ) project
Jabs, D. A., McCluskey, P., Palestine, A. G., Thorne, J. E., & Gr, T. S. O. U. N. W. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14175 · Cited by 57
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP
Bonroy, C., Vercammen, M. J., Fierz, W., Andrade, L. E. C., Hoovels, L. V., Infantino, M. G., Fritzler, M. J., Bogdanos, D. P., Kozmar, A., Nespola, B., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0209 · Cited by 54
Self-citationAntinuclear antibodies and recurrent miscarriage: Systematic review and meta‐analysis
Cavalcante, M. B., Cavalcante, C. T. D. M. B., Sarno, M., da Silva, A. C. B., & Barini, R. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13215 · Cited by 54
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
Sambataro, D., Sambataro, G., Pignataro, F. S., Zanframundo, G., Codullo, V., Fagone, E., Martorana, E., Ferro, F., Orlandi, M., Papa, N. D., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10040208 · Cited by 54
Alexanderson, H., & Boström, C. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101547 · Cited by 53
Zarbl, J., Eimer, E., Gigg, C., Bendzuck, G., Korinth, M., Elling-Audersch, C., Kleyer, A., Simón, D., Boeltz, S., Krusche, M., et al. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002641 · Cited by 51
Differential impact of environmental factors on systemic and localized autoimmunity
Touil, H., Mounts, K., & Jager, P. L. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147447 · Cited by 57
Metadata
- Authors
- Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., Jayne, D., Cervera, R., Costedoat‐Chalumeau, N., Diamond, B., Gladman, D. D., Hahn, B., Hiepe, F., Jacobsen, S., Khanna, D., Lerstrøm, K., Massarotti, E., McCune, J., Ruiz‐Irastorza, G., Sanchez‐Guerrero, J., Schneider, M., Urowitz, M., Bertsias, G., Hoyer, B. F., Leuchten, N., Tani, C., Tedeschi, S. K., Touma, Z., Schmajuk, G., Anic, B., Assan, F., Chan, T. M., Clarke, A. E., Crow, M. K., Czirják, L., Doria, A., Graninger, W., Halda‐Kiss, B., Hasni, S., Izmirly, P. M., Jung, M., Kumánovics, G., Mariette, X., Padjen, I., Pego‐Reigosa, J. M., Romero‐Diaz, J., Rúa‐Figueroa Fernández, Í., Seror, R., Stummvoll, G. H., Tanaka, Y., Tektonidou, M. G., Vasconcelos, C., Vital, E. M., Wallace, D. J., Yavuz, S., Meroni, P. L., Fritzler, M. J., Naden, R., Dörner, T., & Johnson, S. R.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- Brigham and Women's Hospital (US)
- San Francisco VA Medical Center (US)
- Heinrich Heine University Düsseldorf (DE)
- University of Pisa (IT)
- Northwestern University (US)
- Medical University of Vienna (AT)
- University of California, San Francisco (US)
- National and Kapodistrian University of Athens (GR)
- Medical University of South Carolina (US)
- University of Cambridge (GB)
- Hospital Clínic de Barcelona (ES)
- Cochin Hospital Center de référence maladies auto‐immunes et systémiques rares d'île de France Paris France
- Feinstein Institute for Medical Research (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- Humboldt-Universität zu Berlin (DE)
- Copenhagen University Hospital (DK)
- University of Michigan (US)
- Lupus Europe Essex UK
- University of the Basque Country (ES)
- Mount Sinai Hospital/University Health Network University of Toronto, Toronto, Ontario, Canada and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico
- University of Crete (GR)
- University of Zagreb School of Medicine and University Hospital Center Zagreb Zagreb Croatia
- Université Paris-Sud (FR)
- University of Hong Kong (HK)
- University of Calgary (CA)
- Hospital for Special Surgery (US)
- University of Pecs (HU)
- University of Padua (IT)
- Medical University of Graz (AT)
- University of Pécs Pécs Hungary
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- New York University (US)
- AP‐HP, Hôpitaux universitaires Paris‐Sud – Hôpital Bicêtre and Université Paris‐Sud INSERM UMR 1184 Université Paris‐Saclay Le Kremlin Bicêtre France
- University Hospital Centre Zagreb (HR)
- University Hospital of Vigo IRIDIS Group Instituto de Investigación Sanitaria Galicia Sur (IISGS) Vigo Spain
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico
- Doctor Negrín University Hospital Las Palmas de Gran Canaria Las Palmas Spain
- Université Paris Sud Hôpitaux Universitaires Paris‐Sud, AP‐HP, INSERM 1184 Le Kremlin‐Bicêtre France
- University of Occupational and Environmental Health Japan (JP)
- Universidade do Porto (PT)
- University of Leeds (GB)
- Cedars-Sinai Medical Center (US)
- Istanbul Bilim University Istanbul Turkey
- IRCCS Istituto Auxologico Italiano (IT)
- McMaster University (CA)
- Mount Sinai Hospital (CA)
- Corresponding author
- Aringer, Martin
- Johnson, Sindhu R.
- ORCID
- Aringer, Martin
- Costenbader, Karen
- Brinks, Ralph
- Mosca, Marta
- Ramsey‐Goldman, Rosalind
- Smolen, Josef S.
- Wofsy, David
- Boumpas, Dimitrios T.
- Kamen, Diane L.
- Jayne, David
- Cervera, Ricard
- Diamond, Betty
- Gladman, Dafna D.
- Hiepe, Falk
- Jacobsen, Søren
- Khanna, Dinesh
- Massarotti, Elena
- Ruiz‐Irastorza, Guillermo
- Schneider, Matthias
- Urowitz, Murray
- Bertsias, George
- Hoyer, Bimba F.
- Leuchten, Nicolai
- Tani, Chiara
- Tedeschi, Sara K.
- Touma, Zahi
- Schmajuk, Gabriela
- Assan, Florence
- Chan, Tak Mao
- Clarke, Ann Elaine
- Crow, Mary K.
- Doria, Andrea
- Graninger, Winfried
- Hasni, Sarfaraz
- Izmirly, Peter M.
- Jung, Michelle
- Padjen, Ivan
- Pego‐Reigosa, José M.
- Tanaka, Yoshiya
- Tektonidou, Maria G.
- Vasconcelos, Carlos
- Vital, Edward M.
- Wallace, Daniel J.
- Meroni, Pier Luigi
- Fritzler, Marvin J.
- Dörner, Thomas
- Johnson, Sindhu R.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2019-08-06
- Volume
- 71
- Issue
- 9
- Pages
- 1400-1412
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- PMC
- PMC6827566
- OpenAlex
- W2965565685
- Cited by
- 2,677
- References
- 36
- Citations by year
- 2026: 428 · 2025: 497 · 2024: 447 · 2023: 420 · 2022: 367 · 2021: 301 · 2020: 184 · 2019: 27
- FWCI
- 166.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arthritis & Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- European League Against Rheumatism
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, antinuclear antibodies, weighted criteria, multi-criteria decision making, antiphospholipid antibodies, complement proteins, sensitivity and specificity, SLICC 2012 criteria
- MeSH terms
- Adult, Antibodies, Antinuclear, Autoantibodies, Complement System Proteins, Decision Support Techniques, Delphi Technique, Europe, Female, Humans, International Cooperation, Lupus Erythematosus, Systemic, Male, Middle Aged, Rheumatology, Sensitivity and Specificity, Societies, Medical, United States, Cohort Studies, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
